News
CI
336.38
+0.90%
3.01
Weekly Report: what happened at CI last week (0513-0517)?
Weekly Report · 1d ago
Our Top 10 Dividend Growth Stocks - May 2024
Our Top 10 Dividend Growth Stocks - May 2024. This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. The article provides a step-by-step guide on structuring a portfolio based on this strategy. Olivier Le Moal selects the top ten names from an initial list of nearly 400 dividend stocks.
Seeking Alpha · 3d ago
RSI Alert: The Cigna Group Now Oversold
NASDAQ · 4d ago
The Medicare Bubble Has Burst -- Heard on the Street
Medicare Advantage plans have been booming for years. But the Biden administration has made changes to the program. The surge in seniors' medical costs has caught insurers by surprise. CVS Health is one of the biggest losers in the Medicare Advantage market. The private Medicare Advantage business is still expected to be profitable in the future.
The Wall Street Journal · 4d ago
Larry Robbins' Glenview Capital takes in Broadcom, exits Intel among Q1 moves
Seeking Alpha · 5d ago
CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
Seeking Alpha · 6d ago
Burry's Scion Asset adds Cigna, BP, exits Oracle, CVS, among Q1 buys, sells
Seeking Alpha · 6d ago
Michael Burry's Scion Asset Management 13F Reports 360K Shares Of JD, 125K Shares Of BABA, 25K Shares Of HCA, 125K Shares Of C, 440,729K Shares Of PHYS, 90K Shares Of SQ, 20K Shares Of CI, 85K Shares Of AAP, 175K Shares Of BP, 125K Shares Of VTLE, 250K Shares Of SBLK, 1,412,692 Shares Of REAL, 30K Shares Of FSLR, 40K Shares Of BIDU, 400K Shares Of SB
Benzinga · 6d ago
Truist Financial Remains a Buy on Cigna (CI)
TipRanks · 6d ago
Which Healthcare Stock Is A Better Pick – UnitedHealth Group Or CVS Health?
NASDAQ · 05/15 03:51
Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2024 Update
Davis Selected Advisers' 13F portfolio value increased to $ in Q1 2024. The number of holdings decreased from 103 to 98. The top three holdings in the portfolio are Berkshire Hathaway, Meta Platforms, and Capital One Financial. Stake increases were seen in Humana Inc. And MGM Resorts International.
Seeking Alpha · 05/14 02:19
Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now
The Cigna Group is likely to deliver double-digit annual total returns through 2026. The company's total revenue and non-GAAP EPS each surpassed analysts' expectations in Q1. Shares of the managed care provider could be trading 15% below fair value. The managed healthcare and health insurer has a track record of consistent earnings growth.
Seeking Alpha · 05/13 11:00
Weekly Report: what happened at CI last week (0506-0510)?
Weekly Report · 05/13 09:29
CI Quantitative Stock Analysis
NASDAQ · 05/11 15:07
Looking Into Cigna Group's Recent Short Interest
Cigna Group's short percent of float has fallen 29.44% since its last report. The company has 3.95 million shares sold short, which is 1.39% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 05/10 19:30
Noteworthy Thursday Option Activity: CI, PLNT, CDLX
NASDAQ · 05/09 19:47
House committee advances PBM legislation that would charge flat fee for services
Healthcare House committee advances PBM legislation that would charge flat fee for services. Bill would change how pharmacy benefit managers who work with Medicare are paid for their services. The House Ways and Means Committee marked up and advanced the legislation. The legislation would mandate that PBM compensation be determined away from the cost of a drug and use a flat fee.
Seeking Alpha · 05/09 18:26
Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00. The company reported strong first-quarter results with increased revenue and growth in key metrics. Teva has a positive business outlook for 2024, with a forecast for adjusted EBITDA of up to $5.0 billion.
Seeking Alpha · 05/09 12:15
Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture
The Cigna Group's (NYSE:CI) earnings per share fell back over the last year. The company's US$2.1b expense attributed to unusual items detracted from its profits. Unusual items are often not repeated in the majority of cases. We consider the company to have understated its earnings potential. To understand the impact of unusual items, we look at the company's profit.
Simply Wall St · 05/09 11:36
See Which Of The Latest 13F Filers Holds The Cigna Group
NASDAQ · 05/08 14:26
More
Webull provides a variety of real-time CI stock news. You can receive the latest news about Cigna Group through multiple platforms. This information may help you make smarter investment decisions.
About CI
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.